Table 2.
Correlation between expression of NF-κBP65 protein, hTERT mRNA and protein and clinicopathological features
| Factor | Cases | NF-κB | hTERT | hTERT |
| P65 (%) | mRNA (%) | protein (%) | ||
| Gender | ||||
| Male | 30 | 16 (53.33) | 24 (80.00) | 24 (80.00) |
| Female | 11 | 9 (81.82) | 11 (100.00) | 8 (72.73) |
| Age (years) | ||||
| < 60 | 24 | 14 (58.33) | 21 (87.50) | 20 (83.33) |
| ≥ 60 | 17 | 11 (64.71) | 14 (82.35) | 12 (70.59) |
| Histology (type) | ||||
| Intestinal | 16 | 7 (43.75) | 12 (75.00) | 10 (62.50) |
| Differentiation | 25 | 18 (72.00) | 23 (92.00) | 22 (88.00) |
| Differentiation | ||||
| Well | 13 | 3 (23.08)b | 9 (69.23) | 7 (53.85)a |
| Poor | 28 | 22 (78.57) | 26 (92.86) | 25 (89.29) |
| Lymph node metastasis | ||||
| Negative | 16 | 4 (25.00)b | 12 (75.00) | 9 (56.25)a |
| Positive | 25 | 21 (84.00) | 23 (92.00) | 23 (92.00) |
| Stage | ||||
| Early | 12 | 2 (16.67)b | 7 (58.33)b | 5 (41.67)b |
| Advanced | 29 | 23 (79.31) | 28 (96.55) | 27 (93.10) |
| Tumor size (cm) | ||||
| < 5 | 19 | 6 (31.58)b | 14 (73.68) | 13 (68.42) |
| ≥ 5 | 22 | 19 (86.36) | 21 (95.45) | 19 (86.36) |
| Depth of invasion | ||||
| m, sm | 10 | 2 (20.00)a | 6 (60.00) | 4 (40.00)a |
| ms, ss | 17 | 11 (64.71) | 16 (94.12) | 15 (88.24) |
| se, si | 14 | 12 (85.71) | 13 (92.86) | 13 (92.86) |
a
P < 0.05,
b
P < 0.01, From comparison in each group of clinicopatho-logic feature by chi-square test or Fisher’s exact test. m: mucosa, sm: submucosa, mp: muscularis propria, ss: subserosa, se: inva-sion to serosa, si: invasion to other organ. Tumor size was de-fined as the largest size in extension on the gastric mucosa.